These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 7688031)
21. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity. Hart PH; Whitty GA; Piccoli DS; Hamilton JA J Immunol; 1988 Sep; 141(5):1516-21. PubMed ID: 3137258 [TBL] [Abstract][Full Text] [Related]
22. T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro. Vecchiarelli A; Retini C; Pietrella D; Monari C; Kozel TR Eur J Immunol; 2000 May; 30(5):1385-93. PubMed ID: 10820385 [TBL] [Abstract][Full Text] [Related]
23. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts. Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798 [TBL] [Abstract][Full Text] [Related]
24. Prevention and reversal of tumor cell-induced monocyte deactivation by cytokines, purified protein derivative (PPD), and anti-IL-10 antibody. Baj-Krzyworzeka M; Baran J; Szatanek R; Stankiewicz D; Siedlar M; Zembala M Cancer Immun; 2004 Aug; 4():8. PubMed ID: 15327279 [TBL] [Abstract][Full Text] [Related]
25. Regulation by interleukin-3 of human monocyte pro-inflammatory mediators. Similarities with granulocyte-macrophage colony-stimulating factor. Hart PH; Whitty GA; Burgess DR; Hamilton JA Immunology; 1990 Sep; 71(1):76-82. PubMed ID: 2120130 [TBL] [Abstract][Full Text] [Related]
26. CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients. Chougnet C; Thomas E; Landay AL; Kessler HA; Buchbinder S; Scheer S; Shearer GM Eur J Immunol; 1998 Feb; 28(2):646-56. PubMed ID: 9521075 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand. Vidalain PO; Azocar O; Yagita H; Rabourdin-Combe C; Servet-Delprat C J Immunol; 2001 Oct; 167(7):3765-72. PubMed ID: 11564793 [TBL] [Abstract][Full Text] [Related]
28. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Danis VA; Millington M; Hyland VJ; Grennan D Clin Exp Immunol; 1995 Feb; 99(2):303-10. PubMed ID: 7851026 [TBL] [Abstract][Full Text] [Related]
29. Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells. Abe M; Shintani Y; Eto Y; Harada K; Kosaka M; Matsumoto T J Leukoc Biol; 2002 Aug; 72(2):347-52. PubMed ID: 12149426 [TBL] [Abstract][Full Text] [Related]
30. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling. Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160 [TBL] [Abstract][Full Text] [Related]
31. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602 [TBL] [Abstract][Full Text] [Related]
32. CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand). Broxmeyer HE; Lu L; Hangoc G; Cooper S; Hendrie PC; Ledbetter JA; Xiao M; Williams DE; Shen FW J Exp Med; 1991 Aug; 174(2):447-58. PubMed ID: 1713254 [TBL] [Abstract][Full Text] [Related]
33. Evidence that granulocyte/macrophage-colony-stimulating factor and interferon-gamma maintain the viability of human peripheral blood monocytes in part by their suppression of IL-10 production. Bach MK; Brashler JR Int Arch Allergy Immunol; 1995; 107(1-3):90-2. PubMed ID: 7613223 [TBL] [Abstract][Full Text] [Related]
34. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes. Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806 [TBL] [Abstract][Full Text] [Related]
35. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes. Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400 [TBL] [Abstract][Full Text] [Related]
36. Regulation of human monocyte cell-surface and soluble CD23 (Fc epsilon RII) by granulocyte-macrophage colony-stimulating factor and IL-3. Alderson MR; Tough TW; Ziegler SF; Armitage RJ J Immunol; 1992 Aug; 149(4):1252-7. PubMed ID: 1386861 [TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma. Galve-de Rochemonteix B; Nicod LP; Dayer JM Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179 [TBL] [Abstract][Full Text] [Related]
38. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency. Ruppert J; Friedrichs D; Xu H; Peters JH Immunobiology; 1991 Aug; 182(5):449-64. PubMed ID: 1717365 [TBL] [Abstract][Full Text] [Related]
39. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. Alvaro-Gracia JM; Zvaifler NJ; Firestein GS J Clin Invest; 1990 Dec; 86(6):1790-8. PubMed ID: 2174906 [TBL] [Abstract][Full Text] [Related]